SOURCE: EquityPlays.com

February 07, 2013 08:00 ET

The Real Story Behind OREX, CLDX and CHTP

NEW YORK, NY--(Marketwire - Feb 7, 2013) - Moments ago, Equity Plays released another issue of its world-class newsletter in which it took time to review and explain some of the most talked about situations on wall street today.

Give yourself an advantage in today's market. In order to become successful, you need to have information as it happens and understand how it plays out into future stock price. This is our expertise. We know what moves markets. We understand what makes a winner. We translate our extensive research and years of experience into easy-to-understand emails for our subscribers.

Don't waste time trying to figure it out for yourself; tip the scales in your favor and add our experience to your team. Subscription to our complementary real-time newsletter is free and instantly available at the links below.

Orexigen Therapeutics, Inc. (NASDAQ: OREX)
Did you want to hear about OREX at $1.59 on December 19th, 2011? Our next alert is due to be released at a moment's notice, subscribe to www.EquityPlays.com/index.php?d=2013-02-07&s=OREX to catch our next 300% alert. Give yourself the opportunity to turn $10,000 into $40,000 and kick-start your portfolio.

Celldex Therapeutics, Inc. (NASDAQ: CLDX)
Did you want to hear about CLDX at $2.65 on December 27th, 2011? Our next alert is due to be released at a moment's notice, subscribe to www.EquityPlays.com/index.php?d=2013-02-07&s=CLDX to catch our next 300% alert. Give yourself the opportunity to turn $10,000 into $40,000 and kick-start your portfolio.

Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP)
Did you want to hear about CHTP at $1.02 on August 28th, 2012? Our next alert is due to be released at a moment's notice, subscribe to www.EquityPlays.com/index.php?d=2013-02-07&s=CHTP to catch our next 300% alert. Give yourself the opportunity to turn $10,000 into $40,000 and kick-start your portfolio.

For more on OREX, CLDX and CHTP as it happens in real-time, subscribe to our newsletter at the links above.

Contact Information